Welcome to Valicare!
Do you have questions about the GMP compliance of your ATMP? Or are you looking for a turnkey production solution for your ATMP? Take a look at the services our experts offer or contact us directly.Learn more
Events where you can meet Valicare experts
02 Jun 2022Online ATMP Lecture, 02.06.2022 Dr. Hans-Georg Eckert, Senior GMP Consultant at Valicare GmbH and lecturer at the Fresenius University of Applied Sciences in Idstein, Germany, will give a block lecture on advanced therapy medicinal products (ATMPs) on June 02, 2022.
05 Jul 202206 Jul 2022Leipzig / Germany ISPE D/A/CH ATMP Workshop in Leipzig In the workshop "ATMP in the light of Annex 1 DRAFT", discussions will be held together with pharmaceutical companies, machine manufacturers and representatives of the authorities Both technical and regulatory aspects will be taken into account.
News from around the world
Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).
Early Trial Data Show Crispr Cancer Therapy Response13.05.2022 | Science & Enterprise
13 May 2022. Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a ...
CRISPR Therapeutics’ CAR-T for Lymphoma Shows Early Promise12.05.2022 | BioSpace
05.12.22 -- Your New EU IDMP Implementation Strategy12.05.2022 | Pharmaceutical Online
On Cell & Gene: The Podcast, Amit Kumar, Ph.D., CEO at Anixa Biosciences, details the progress on their Phase 1 trial for ovarian cancer ...
Repairing tendons with silk proteins12.05.2022 | Orthopaedic Product News
Sudden or repetitive motion, experienced by athletes and factory workers, for example, increases the risk of tears or ruptures in the ...
A guide to the organ-on-a-chip12.05.2022 | Nature
Organs-on-chips (OoCs) are systems containing engineered or natural miniature tissues grown inside microfluidic chips. To better mimic ...
On the Prognostic Power of Tumor-Infiltrating Lymphocytes – A Critical Commentary12.05.2022 | Frontiers
Introduction Tumor-infiltrating lymphocytes can affect cancer progression. Tumor-infiltrating lymphocytes may generally be classified as ...
Recent Advances in Chitosan and its Derivatives in Cancer Treatment11.05.2022 | Frontiers
1 Introduction Cancer has been becoming a life-threatening disease and a major public health problem all over the world, which is one of ...
Scaling Up Cell Therapies Capacity11.05.2022 | BioPharm International
Outsourcing partners are ready to fill the market need for greater cell therapies capacities.
Shining a Spotlight on Nucleic Acid-Based Therapeutics11.05.2022 | BioPharm International
Further development of nucleic acid-based therapeutics has been accelerated by the recent success of mRNA vaccines.
BioNTech Forges Ahead in Oncology, Infectious Disease10.05.2022 | PharmaLive
BioNTech Forges Ahead in Oncology, Infectious Disease
Bone Therapeutics is Breaking New Ground in Bone Remodeling09.05.2022 | BioSpace
Neues aus dem Tissue Engineering: Wie der 3D-Druck hilft09.05.2022 | medizin & technik
Gestärkte Immunzellen für den Kampf gegen Krebs07.05.2022 | Krebs-Nachrichten
Gut microbiome as a tool in regenerative medicine; Novel approach driven by GN Corp Japan with potentials in neurological illnesses07.05.2022 | American Press
Regenerative medicine uses tools that include cells (stem cells, progenitors, mature adult cells), cell-derived factors (cytokines), and ...
Bispecific Antibodies With Multiple Targets Moving Forward in Multiple Myeloma06.05.2022 | The Asco Post
Poor outcomes are observed in patients with myeloma who are refractory to multiple classes of therapies, with the average patient ...